Comparison of Vaccination Regimens on Immune Responses Using PED Replicon Vaccine: A Field Trial in PED-Negative and PED-Positive Thai Swine Farms by Chaitawat Sirisereewan, Thanh Che Nguyen, Nanthiya Iampraphat, Hongyao Lin, Leonardo Ellerma, Pisit Sirithanyakul, Roongtham Kedkovid, Roongroje Thanawongnuwech

Subjects: Get full text

Post-marketing safety surveillance for the recombinant zoster vaccine (Shingrix), vaccine adverse event reporting system, United States, October 2017–April 2024 by Yamin Shu, Wenxin Cheng, Xucheng He, Liu Huang, Wei Chen, Qilin Zhang

Subjects: “…Vaccine safety…”
Get full text

Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015–2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) by Po-Han Huang, Mary Patricia Nowalk, Richard K. Zimmerman, Samantha M. Olson, H. Keipp Talbot, Yuwei Zhu, Manjusha Gaglani, Kempapura Murthy, Arnold S. Monto, Emily T. Martin, Fernanda P. Silveira, G.K. Balasubramani

Subjects: Get full text

Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia by Zoe L. Lyski, Myung Sun Kim, David Xthona Lee, David Sampson, Hans-Peter Raué, Vikram Raghunathan, Debbie Ryan, Amanda E. Brunton, Mark K. Slifka, William B. Messer, Stephen E. Spurgeon

“…It is important to understand the role a heterologous boost would have in patients who did not respond to the initial two-dose mRNA vaccine series. SARS-CoV-2 specific immune responses, including antibodies and memory B-cells, CD4 and CD8 T-cells were assessed prior to vaccination, as well as postinitial vaccination series and post-third dose in two subjects. …”
Get full text

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents by Amparo L. Figueroa, Kashif Ali, Gary Berman, Wenqin Xu, Weiping Deng, Bethany Girard, Anne Yeakey, Karen Slobod, Jacqueline Miller, Rituparna Das, Frances Priddy

Subjects: “…mRNA vaccine…”
Get full text

Neonatal and Infantile Immune Responses to Encapsulated Bacteria and Conjugate Vaccines by Peter Klein Klouwenberg, Louis Bont

“…These and several other approaches in current vaccine development will be discussed.…”
Get full text

Diarrheal Diseases Hospitalization in Yemen before and after Rotavirus Vaccination by Mohammed Amood AL-Kamarany, Lina Al-Areqi, Abulatif Mujally, Fawzya Alkarshy, Arwa Nasser, Aisha O. Jumaan

“…The study aims to assess the impact of rotavirus vaccine introduction on diarrheal diseases hospitalization and to identify the rotavirus genotypes most prevalent before and after vaccine introduction among children ≤ 5 years of age. …”
Get full text

Improvement of inactivated vaccine against porcine reproductive respiratory syndrome by D. A. Biruchenkov, Ye. P. Baborenko, Ye. A. Avsitidiysky, D. L. Dolgov, Zh. Yu. Muradyan, A. I. Albulov

Subjects: Get full text

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers by Susanna Esposito, Claudia Tagliabue, Samantha Bosis

“…The three purified protein conjugate vaccines currently available target serogroups A, C, W, and Y. …”
Get full text

IAPSM’s Position Paper on Typhoid Vaccines for Adult Immunization in India by Kapil Goel, Madhur Verma, Nikita Sharma, Swayam Pragyan Parida, Anu Bhardwaj, Anuradha Nadda, Sahil Sharma, Arunima Sen, Jacob John, Adarsh Bansal, Madhu Gupta

Subjects: Get full text

Advancing veterinary vaccines design through trained immunity insights by Xin Wang, Xin Wang, Xin Wang, Xin Wang, Guohua Yu, Guohua Yu, Guohua Yu

Subjects: Get full text

Postinfluenza Vaccination Idiopathic Thrombocytopenic Purpura in Three Elderly Patients by Joji Nagasaki, Masahiro Manabe, Kentaro Ido, Hiroyoshi Ichihara, Yasutaka Aoyama, Tadanobu Ohta, Yoshio Furukawa, Atsuko Mugitani

“…We report the cases of three elderly patients who developed ITP after receiving influenza vaccinations. The platelet count of an 81-year-old woman fell to 27,000/μL after she received an influenza vaccination. …”
Get full text

IAPSM’s Position Paper on Influenza Vaccines for Adult Immunization in India by Nikita Sharma, Madhur Verma, Kapil Goel, Muralidhar M. Kulkarni, Anu Bhardwaj, Sahil Sharma, Tejbeer Singh, Madhu Gupta, Anuradha Nadda, Lalit R. Sankhe

Subjects: Get full text

Viral Live‐Attenuated Vaccines (LAVs): Past and Future Directions by Yan‐Dong Tang, Yuming Li, Xue‐Hui Cai, Xin Yin

Subjects: Get full text

Evaluation of nigella sativa's cold press oil as vaccine adjuvant by Uçkun Sait Uçan, Aslı Sakmanoğlu, Ali Uslu, Zafer Sayın, Ecem Oğlakçı Cansoy

Get full text

Editorial: Pathogen-induced immunosenescence: where do vaccines stand? by Mehrnoosh Doroudchi, Hamed Fouladseresht

Subjects: Get full text

Examining vaccination-related adverse events in frequent neurodegenerative diseases by Shabnam Sodagari, Nassim Sodagari

Subjects: Get full text

Immunogenicity of RSV F DNA Vaccine in BALB/c Mice by Erdal Eroglu, Ankur Singh, Swapnil Bawage, Pooja M. Tiwari, Komal Vig, Shreekumar R. Pillai, Vida A. Dennis, Shree R. Singh

“…With a focus on Th1 immunity, we developed a DNA vaccine containing the native RSV fusion (RSV F) protein and studied its immune response in BALB/c mice. …”
Get full text

Dynamical Models for Infectious Diseases with Varying Population Size and Vaccinations by Peilin Shi, Lingzhen Dong

“…We formulate and discuss models for the spread of infectious diseases with variable population sizes and vaccinations on the susceptible individuals. First, we assume that the susceptible individuals are vaccinated continuously. …”
Get full text

Mumps Caused by an Inadequately Attenuated Measles, Mumps and Rubella Vaccine by WJ Bakker, RG Mathias

Get full text